The recent studies have reported that FST was aberrantly expressed in human lung adenocarcinoma cells, suggesting that FST might be a potential biomarker for diagnosis of lung adenocarcinoma [22, 24]. This evidence concerns the gene FST and lung adenocarcinoma.